FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 02/01/2024 |
3. Issuer Name and Ticker or Trading Symbol
Fractyl Health, Inc. [ GUTS ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 82,162 | I | Directly held by General Catalyst Group V, L.P.(1) |
Common Stock | 1,714 | I | Directly held by GC Entrepreneurs Fund V, L.P.(1) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Series A Preferred Stock | (2) | (2) | Common Stock | 1,493,397 | (2) | I | Directly held by General Catalyst Group V, L.P.(1) |
Series A Preferred Stock | (2) | (2) | Common Stock | 31,172 | (2) | I | Directly held by GC Entrepreneurs Fund V, L.P.(1) |
Series B Preferred Stock | (2) | (2) | Common Stock | 1,443,931 | (2) | I | Directly held by General Catalyst Group V, L.P.(1) |
Series B Preferred Stock | (2) | (2) | Common Stock | 30,140 | (2) | I | Directly held by GC Entrepreneurs Fund V, L.P.(1) |
Series C-1 Preferred Stock | (2) | (2) | Common Stock | 612,527 | (2) | I | Directly held by General Catalyst Group V, L.P.(1) |
Series C-1 Preferred Stock | (2) | (2) | Common Stock | 12,785 | (2) | I | Directly held by GC Entrepreneurs Fund V, L.P.(1) |
Series C-2 Preferred Stock | (2) | (2) | Common Stock | 623,329 | (2) | I | Directly held by General Catalyst Group V, L.P.(1) |
Series C-2 Preferred Stock | (2) | (2) | Common Stock | 13,011 | (2) | I | Directly held by GC Entrepreneurs Fund V, L.P.(1) |
Series D Preferred Stock | (2) | (2) | Common Stock | 422,560 | (2) | I | Directly held by General Catalyst Group V, L.P.(1) |
Series D Preferred Stock | (2) | (2) | Common Stock | 8,820 | (2) | I | Directly held by GC Entrepreneurs Fund V, L.P.(1) |
Series E Preferred Stock | (2) | (2) | Common Stock | 106,417 | (2) | I | Directly held by General Catalyst Group V, L.P.(1) |
Series E Preferred Stock | (2) | (2) | Common Stock | 2,221 | (2) | I | Directly held by GC Entrepreneurs Fund V, L.P.(1) |
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
Explanation of Responses: |
1. General Catalyst GP V, LLC ("GCGPV") is the general partner of General Catalyst Partners V, L.P., which is the general partner of General Catalyst Group V, L.P. ("GCGV") and GC Entrepreneurs Fund V, L.P. ("GCEV"). GCGPV is controlled by a group of three or more individuals, or the Managing Directors, having shared voting and dispositive control over the shares held by GCGV and GCEV. Each of the Managing Directors disclaims beneficial ownership of the securities held by GCGV and GCEV except to the extent of his or her pecuniary interest therein, if any. |
2. Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election in accordance with the terms of such preferred stock and has no expiration date. The preferred stock will automatically convert into common stock upon the closing of the Issuer's initial public offering. |
General Catalyst GP V, LLC, By: /s/ Lisa A. Davidson, Attorney-in-fact | 02/01/2024 | |
General Catalyst Partners V, L.P., By: General Catalyst GP V, LLC, its general partner, By: /s/ Lisa A. Davidson, Attorney-in-fact | 02/01/2024 | |
General Catalyst Group V, L.P., By: General Catalyst Partners V, L.P., its general partner, By: General Catalyst GP V, LLC, its general partner, By: /s/ Lisa A. Davidson, Attorney-in-fact | 02/01/2024 | |
GC Entrepreneurs Fund V, L.P., By: General Catalyst Partners V, L.P., its general partner, By: General Catalyst GP V, LLC, its general partner, By: /s/ Lisa A. Davidson, Attorney-in-fact | 02/01/2024 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |